rs150244426
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_181882.3(PRX):c.1222C>T(p.Pro408Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000147 in 1,614,156 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_181882.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRX | NM_181882.3 | c.1222C>T | p.Pro408Ser | missense_variant | 7/7 | ENST00000324001.8 | NP_870998.2 | |
PRX | NM_001411127.1 | c.1507C>T | p.Pro503Ser | missense_variant | 7/7 | NP_001398056.1 | ||
PRX | XM_017027047.2 | c.1120C>T | p.Pro374Ser | missense_variant | 4/4 | XP_016882536.1 | ||
PRX | NM_020956.2 | c.*1427C>T | 3_prime_UTR_variant | 6/6 | NP_066007.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRX | ENST00000324001.8 | c.1222C>T | p.Pro408Ser | missense_variant | 7/7 | 1 | NM_181882.3 | ENSP00000326018.6 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000271 AC: 68AN: 251096Hom.: 0 AF XY: 0.000412 AC XY: 56AN XY: 135838
GnomAD4 exome AF: 0.000151 AC: 221AN: 1461820Hom.: 3 Cov.: 35 AF XY: 0.000220 AC XY: 160AN XY: 727216
GnomAD4 genome AF: 0.000112 AC: 17AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74494
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 21, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in individuals with suspected Charcot-Marie-Tooth disease in published literature (Volodarsky et al., 2021); This variant is associated with the following publications: (PMID: 32376792) - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | PRX: BP4 - |
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Molecular Genetics Laboratory, London Health Sciences Centre | - | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2021 | The p.P408S variant (also known as c.1222C>T), located in coding exon 4 of the PRX gene, results from a C to T substitution at nucleotide position 1222. The proline at codon 408 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Charcot-Marie-Tooth disease type 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 26, 2022 | This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 408 of the PRX protein (p.Pro408Ser). This variant is present in population databases (rs150244426, gnomAD 0.2%). This missense change has been observed in individual(s) with clinical features of Charcot-Marie-Tooth disease (PMID: 32376792). ClinVar contains an entry for this variant (Variation ID: 444468). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at